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Children and young people with intellectual disability and/or Autism Spectrum Disorder 18 
(autism) experience higher rates of mental health problems, including depression, than their 19 
typically developing peers. While international guidelines suggest psychological therapies as 20 
first line intervention for children and young people, there is limited research evidence for 21 
psychological therapy for depression in children and young people with intellectual disability 22 
and/or autism.  23 
Aims 24 
To evaluate the current evidence base for psychological interventions for depression in 25 
children and young people with an intellectual disability and/or autism, and examine the 26 
experiences of children and young people with intellectual disability and/or autism, their 27 
families, and therapists, in receiving and delivering psychological treatment for depression.  28 
Method 29 
Databases were searched up to 30 April 2020 using pre-defined search terms and criteria. 30 
Articles were independently screened and assessed for risk of bias. Data were synthesised and 31 
reported in a narrative review format.  32 
Results 33 
A total of 10 studies met inclusion criteria. Four identified studies were clinical case reports 34 
and six were quasi-experimental or experimental studies. All studies were assessed as being 35 
of moderate or high risk of bias. Participants with intellectual disability were included in four 36 
studies. There was limited data on the experiences of young people, their families, or 37 




Well-designed randomised controlled trials are critical to develop an evidence base for 40 
psychological treatment for young people with intellectual disability and/or autism with 41 
depression. Future research should evaluate young people, family, and therapist experience of 42 




Mental health disorders have been found to be three to five times more prevalent in children 45 
and adolescents with intellectual disability compared to their typically developing peers1, 2. 46 
Consistent with this general mental health inequity, adolescents with intellectual disability, 47 
Autism Spectrum Disorder (hereafter referred to as autism), or both conditions are at higher 48 
risk for depression than their same-age peers1, 3-6. Specifically, children and young people 49 
with intellectual disability are 1.7 times more likely to experience depression compared to 50 
other children5.  Although young people with autism have demonstrated higher rates of 51 
depression than typically developing children and adolescents, reported rates vary 52 
considerably6.  53 
Treatment for mental health problems in people with intellectual disability has historically 54 
relied on pharmacological approaches7, 8.  However, international guidelines and 55 
recommendations suggest that first line treatments for depression in children and young 56 
people should include psychological therapies9, 10. There is some support for the use of 57 
cognitive behavioural therapy for depression in adults with mild-moderate intellectual 58 
disability7 but a lack of research focus on children and adolescents.  Research evidence for 59 
the psychological treatment of depression in children and adolescents with autism is available 60 
but limited, with the evidence to-date focused on the treatment of anxiety or disruptive 61 
behaviours11, 12.  The current study, therefore, had the following review questions: (1) What is 62 
the current evidence base for psychological interventions for depression in children and 63 
young people with an intellectual disability and/or autism?, (2) What are the experiences of 64 
children and young people with intellectual disability and/or autism and their family members 65 
of psychological intervention for depression?, and (3) What are the experiences of therapists 66 
delivering psychological intervention  for depression to children and young people with 67 




The review protocol was prospectively registered with the International Prospective Register 70 
of Systematic Reviews (PROSPERO, registration number CRD42019145495) and can be 71 
accessed here: 72 
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42019145495. The review 73 
was conducted and is reported in accordance with the Preferred Reporting Items for 74 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines 13.  75 
Search strategy 76 
PsycINFO, MEDLINE, Embase via Elsevier, CINAHLPlus, Social Sciences Index and 77 
Sciences Index via Web of Science, and Scopus databases were searched by two authors 78 
(L.A.C and K.P.) on 1st May 2020 for articles published from inception to 30th April 2020. 79 
Searches were conducted using keywords identified for each domain (see Table 1 for an 80 
example search string) and limited to articles written in English. Hand searching of reference 81 
lists and citation searching of included studies were also conducted to identify potential 82 
additional articles. 83 
[INSERT TABLE 1 ABOUT HERE] 84 
Inclusion/exclusion criteria 85 
Studies were included if they met the following criteria: 86 
a) Study design: pre-post single group designs, case series, clinical case reports, single 87 
case experimental designs, and qualitative studies. Studies with a comparison group, 88 
control group, or no control group were all included. Observational and case-control 89 
studies involving no treatment were excluded. 90 
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b) Participants: children, adolescents, or young people up to age 21 years with an 91 
intellectual disability (including borderline intellectual disability) and/or autism. 92 
Studies were included if the entire sample included the relevant population, or if 93 
outcomes were reported separately for the relevant population.  Studies that involved 94 
young people up to the age of 25 years were included if 75% of the sample was under 95 
21 years.  96 
c) Participant diagnosis: either (i) major depressive disorder as diagnosed by 97 
standardised criteria (e.g. the Diagnostic and Statistical Manual for Mental Disorders, 98 
International Classification of Diseases, Diagnostic Manual-Intellectual Disability), 99 
(ii) dysthymia or minor depression as diagnosed by standardised criteria, or (iii) 100 
depressive status, as defined by meeting cut-offs on a standardised depression 101 
screening questionnaire (e.g., Children’s Depression Inventory14, Beck Depression 102 
Inventory15, Glasgow Depression Scale16). 103 
d) Treatment or intervention: any psychological or psychosocial intervention (e.g. life 104 
skills training, lifestyle intervention) with the aim of treating depression or depressive 105 
symptoms. Pharmacological or medical treatments, transcranial magnetic stimulation, 106 
complementary, and alternative therapies and treatments were excluded.  107 
Screening 108 
First stage title and abstract screening was undertaken by two authors (L.A.C. and K.P.) to 109 
identify any articles that were clearly not relevant to the review, with a randomly selected 110 
20% screened by both authors to determine interrater reliability. Agreement was 99.1% 111 
(kappa 0.940). Full text review was independently undertaken by the same two authors with 112 
any conflicts of inclusion/exclusion resolved through discussion, and consultation with 113 





Data extraction 117 
Data were extracted from each article and coded for: (a) study information (type of study, 118 
country of publication, year of publication), (b) participant information (age, gender, 119 
intellectual disability/autism diagnosis), (c) assessment of depression, (d) treatment 120 
information (type of treatment/intervention, length of treatment, length of follow-up), and (e) 121 
study outcomes.  122 
Risk of bias 123 
Risk of bias assessments were conducted by a panel of four authors (L.A.C., K.P., G.A.M., 124 
and K.M.G.). Assessments of controlled and uncontrolled trials were conducted using pre-125 
developed proformas based on the Cochrane risk of bias tool and the Newcastle Ottawa 126 
Scale17, 18. These proformas have been used previously in large international systematic 127 
reviews e.g. Blackmore et al. 19. Single case studies and case series were appraised using 128 
criteria described by Horner et al. 20. Each study was assessed overall as being of low, 129 
moderate, or high risk of bias.  130 
Results 131 
A total of 13,936 records were retrieved in the search. After removal of duplicates, 9,343 132 
records remained for abstract and title screening. A further 9,231 records were excluded, 133 
leaving 114 for full text review. No additional articles were identified through reference lists 134 
of included studies or forward citation searching. A total of 10 studies met inclusion criteria 135 
(Figure 1). 136 
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Summary data for all included studies, including sample description, assessment of 137 
depression, description of treatment and treatment duration, outcome measures, and study 138 
results related to the impact of treatment on depression or depressive symptoms, can be 139 
viewed in Tables 2 and 3. 140 
Research Question 1: What is the evidence base for psychological interventions for 141 
depression for children and young people with intellectual disability and/or autism? 142 
Of the 10 included studies, four were clinical case reports21-24, and the remaining six were 143 
experimental or quasi-experimental designs, including: one multiple baseline design study25, 144 
two uncontrolled group design trials26, 27, and three controlled group design trials28-30.  145 
Clinical case reports  146 
Across the four clinical case reports, n = 5 participants were described (n = 3 male, ages 147 
ranging from 12 – 18 years).  One clinical case report used a combination of psychotherapy 148 
and behavioural training to target depressive symptoms in a 17 year old female with a mild 149 
intellectual disability21. Three clinical case reports used adapted versions of cognitive 150 
behavioural therapy (CBT) with a 12 year old male22, a 17 year old female23, and two males 151 
aged 17 and 18 years old24, all with Asperger Syndrome.   152 
Three clinical case reports utilising CBT adapted their programme for young people with 153 
autism. Greig and MacKay 22 highlight that their CBT programme, The Homunculi, involves 154 
the creation of characters to help the individual to visualise various processes and behaviours. 155 
Loades 23 reported that the CBT programme was adapted for their participant with Asperger 156 
Syndrome, but did not describe what these adaptations involved. Selvapandiyan 24 157 
implemented pragmatic CBT 31, described by the author as being designed to target the social 158 
communication difficulties evident in Asperger Syndrome. The duration of treatment varied 159 
across the clinical case reports, ranging from 15 individual sessions to eight months. 160 
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Behavioural training was more intensive, with sessions being undertaken almost daily, while 161 
CBT was undertaken weekly. Behavioural training in these instances involved behavioural 162 
modification of identified behaviours, including compliance, lack of interest, oppositional 163 
behaviours, and self-harm21. 164 
Three clinical case reports relied on questionnaires to assess change in depressive symptoms 165 
over the course of treatment22-24. One clinical case report used the depression scale of the 166 
Briere Trauma Scales (self-report)32 pre- and post-treatment22. Another clinical case report 167 
used the Revised Children’s Anxiety and Depression Scales (self-report)33 at pre-treatment 168 
and throughout the course of treatment at sessions 6, 12 and 20 weeks23. The remaining 169 
clinical case report used the Hamilton Depression Rating Scale (HDRS)34, rated by the 170 
clinician at the end of each treatment session. The study reported that progress was monitored 171 
over two months post treatment, however, the HDRS scores at follow-up were not reported24.  172 
All clinical case reports reported an improvement in depressive symptoms following the 173 
intervention, whether that was a decrease in problem behaviours21, or a reduction in 174 
depressive scores on screening measures22-24. Maintenance of improvements were reported 175 
for the one clinical case report that included longer term follow-up24. Two of the clinical case 176 
reports reported the use of medication throughout the study period; one introduced 177 
medication (olanzapine and chlorpromazine) at the beginning of the treatment period21, and 178 
the other reported that the client had been prescribed medication 10 weeks prior to the 179 
commencement of the CBT intervention, with a stable dose maintained throughout the 180 
intervention programme23. Neither study considered the potential impact of the medication 181 
when reporting treatment outcomes.  182 
Experimental and quasi-experimental designs 183 
 Multiple-baseline design 184 
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One study employed an experimental multiple baseline across behaviours design with a 10 185 
year old male with borderline intellectual disability (WISC-R IQ = 79)25. The intervention 186 
took place on an inpatient unit, using behavioural treatment to target behaviours deemed to be 187 
reflective of depression in the participant. This included “inappropriate body position”, lack 188 
of eye contact, poor speech quality, and bland affect. Behavioural intervention involved 189 
specific skill training incorporating instruction, modelling, role-playing, and feedback of a 190 
more appropriate response in place of the inappropriate behaviour, over 20 minute sessions 191 
each day. Baseline was established over eight days for all behaviours, followed by 192 
introduction of the behavioural treatment for the first two behaviours simultaneously (six 193 
sessions), the third behaviour (five sessions), and the final behaviour (nine sessions). 194 
Frequency of target behaviours was recorded during each session, with reductions in each 195 
target behaviour observed following the introduction of the intervention, and maintenance 196 
improvements at a 12 week follow-up. While the study involved administration of a number 197 
of depression screening tools during their initial diagnostic process, these were not used to 198 
assess post-treatment outcomes.  199 
 Uncontrolled trials 200 
Two studies were uncontrolled trials. One study was a case series with a pre-post design, 201 
reporting on existing patients seen in an inpatient setting26. This study identified patients (N = 202 
31) with an intellectual disability aged three to 16 years, diagnosed with depression according 203 
to DSM-III35. Gender was not reported. Treatment was described as the standard treatment 204 
used in the clinical setting. Individual psychotherapy was the primary treatment utilised, 205 
although frequency and duration of therapy were not specified. An unspecified number of 206 
participants were prescribed medication when it was clear the psychotherapy alone was not 207 
effective. The timing of the introduction of medication was not reported, and the impact was 208 
not considered in the reporting of outcomes. Outcomes were reported after approximately six 209 
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months of treatment before discharge from the facility. Eighty-seven percent of patients 210 
(n=27) were considered to have shown a clear clinical improvement by the time of discharge. 211 
However, a definition of clinical improvement was not reported, nor was the effect of 212 
medication.  213 
The second pre-post design was an uncontrolled trial involving participants with autism and 214 
no co-occurring intellectual disability (n = 39, 82% male, mean age 10 years) to receive a 215 
structured intervention27. Participants in this study undertook a 12-week group CBT 216 
programme targeting social competence skills. Depressive symptoms were measured at the 217 
beginning and at the end of the treatment programme using the depression subscale score of 218 
the Behavior Assessment System for Children (BASC-II)36, a parent-report measure. No 219 
change was seen in depressive symptoms from the beginning to end of treatment, although 220 
improvements were seen in aggression, emotion control, and autism symptoms.  221 
 Controlled trials 222 
Three studies were controlled trials. One trial evaluated the impact of a lifestyle intervention, 223 
a physical exercise programme, specifically Assisted Cycling Therapy (ACT), in a group of 224 
young people with Down Syndrome (n = 49. 59% male, mean age = 18.3 years (SD = 4.1 225 
years))29. ACT involved the use of a mechanical motor attached to a stationary exercise 226 
bicycle to increase the individual’s cycling rate above their preferred voluntary cycling rate. 227 
Participants were counterbalanced to one of two active treatment groups ACT or Voluntary 228 
Cycling (VC)), although how the counterbalancing was achieved was not described, nor was 229 
it clear whether participants were randomised to each group. A No Cycling (NC) control 230 
group was recruited through convenience sampling, recruited through advertising in local 231 
communities. There were no group differences at baseline in terms of gender, chronological 232 
age, receptive language ability, hours of sport per week, or BMI.  However, the ACT group 233 
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scored significantly higher on a measure of cognitive planning compared to both the VC and 234 
NC groups.  Depression symptomatology was measured both pre- and post-treatment using 235 
the Children’s Depression Inventory (CDI)14, with greater improvements on CDI scores seen 236 
in the ACT group when compared to both the VC and the NC control group at the end of the 237 
eight week therapy. 238 
The second controlled trial reported on the impact of a group CBT programme for young 239 
people with Asperger Syndrome or autism without intellectual disability (n = 42, 72% male, 240 
mean age = 20.6 years (SD = 4.1))28. Participants were allocated to either treatment or 241 
waitlist control according to alternating order of study enrolment (i.e., pseudo-242 
randomisations). The nine week CBT programme was developed with particular regard to the 243 
social difficulties often experienced by young people with autism. Depression was measured 244 
by the Depression subscale of the Depression, Anxiety and Stress Scales (DASS)37 at pre-245 
treatment, post-treatment, and again at three and nine month follow-ups.  There was no 246 
significant difference between the groups post treatment.  However, there was a significant 247 
decrease in DASS Depression scores for those participants with scores in the clinical range at 248 
pre-treatment.  These improvements were maintained at both three and nine month follow-up. 249 
The final controlled study also evaluated a group CBT programme for young people with 250 
autism with no intellectual disability (n = 23, 60% male, mean age = 15.75 years (SD = 251 
1.37))30. Participants were randomly allocated to either waitlist or control via a computer-252 
generated random sequence programme. The ten week group CBT programme was designed 253 
specifically for young people with autism38. Depression was measured using both the DASS 254 
Depression subscale and the Beck Depression Inventory (BDI-II)15 at pre-treatment, post-255 
treatment, and at four and 12 week follow-ups. The authors reported no significant change in 256 
BDI-II scores from pre- to post- treatment, although a significant decrease was seen in DASS 257 





Research Questions 2 and 3: What are the experiences of young people and their 261 
families and treatments for depression? What are the experiences of professionals in 262 
delivering treatment for depression?   263 
No studies were identified that had a focus on evaluating the experiences of young people 264 
with intellectual disability and/or autism and their families in receiving psychological 265 
treatment for depression. Only two of the included studies reporting on treatments for 266 
depression also reported on participant experience22, 30. Santomauro et al. 30 gathered 267 
feedback from 15 young people with autism during their final group booster session, as a 268 
group discussion. Fourteen out of 15 young people reported enjoying the programme, with 269 
the fifteenth participant still recommending the programme for its usefulness. Participants 270 
considered the group setting the most beneficial aspect of the CBT programme. Greig and 271 
MacKay 22 briefly noted that the participant in their single case study felt that the intervention 272 
had worked for him in real life situations.  273 
No studies evaluated the professional or clinician experience of delivering treatment for 274 
depression to children and young people with intellectual disability and/or autism. 275 
Risk of bias 276 
Risk of bias was assessed for all studies. No studies were considered to have a low risk of 277 
bias. All of the clinical case reports (n = 4) were assessed as high risk of bias21-24. Clinical 278 
case reports are inherently biased; they have a high risk of publication bias, they are 279 
retrospective reports and subject to information bias in that they involve subjective 280 
interpretation by the author who is often the treating clinician, outcome assessment measures 281 
are often administered by the clinician, and causal relationships and generalisation are not 282 
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possible due to the nature of describing treatment outcome for one individual, often leading 283 
to overinterpretation of results and treatment effectiveness39. In addition to these overarching 284 
issues, the included clinical case reports had particular problems with outcome measures, 285 
including selecting inappropriate measures, not reporting how scores were calculated, and not 286 
reporting on all outcomes as stated.  287 
Of the quasi-experimental and experimental studies, four studies were rated to have a 288 
moderate risk of bias, including the multiple baseline design25, 28-30 and the remaining two 289 
rated as high risk of bias (both uncontrolled trials)26, 27. Reasons for ratings of moderate and 290 
high risk of bias included: no control group, no or poor randomisation when there was a 291 
control group, outcome measures administered by the clinician delivering treatment, use of 292 
outcome measures with unestablished psychometric properties in intellectual disability and/or 293 
autism, and not considering impact of confounding variables (e.g. medication).  294 
[INSERT TABLES 2 AND 3 ABOUT HERE] 295 
Discussion 296 
This systematic search identified ten studies that evaluated psychological treatments for 297 
depression in children and young people with intellectual disability and/or autism. However, 298 
four of these were clinical case reports with a high risk of bias and thus are unable to directly 299 
inform a research evidence base to guide treatment21-24. The remaining six studies included 300 
four studies with either a single case experimental design25, an uncontrolled group design26, 27 301 
or a controlled group design28-30. The six experimental/quasi-experimental studies each 302 
focused on different treatments, different population groups, used different outcome measures 303 
for depression, and were all rated with a moderate or high risk of bias. Therefore, no 304 
conclusions can be drawn with any confidence about the suitability or effectiveness of any 305 
particular psychological or psychosocial intervention for treating depression in children and 306 
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young people with intellectual disability and/or autism. There was also essentially a complete 307 
lack of information about the experiences of young people or their families who received 308 
psychological intervention for depression, or the therapists who delivered the intervention.   309 
Study design 310 
High quality randomised controlled trials are essential to improve the evidence-base for 311 
effectiveness of these interventions. Only one of the three controlled trials employed 312 
adequate randomisation strategies30, with the others allocating participants based on order of 313 
enrolment28, or through counterbalancing, which was not thoroughly described29. Future 314 
studies should focus on developing well-designed randomised controlled trials to address this 315 
important gap in the literature.  316 
In addition to the need for well-designed trials, future research should evaluate existing 317 
evidence-based psychological and psychosocial treatments for depression adapted 318 
specifically to meet the needs of children and young people with intellectual disability and/or 319 
autism. While a range of psychological and psychosocial interventions were identified in this 320 
review, only two of the experimental studies reported that the intervention used had been 321 
adapted for young people with autism28, 30. Importantly, none of the interventions described 322 
had been adapted for young people with intellectual disability. Development of new 323 
interventions tailored specifically for this population is also important. New interventions 324 
should be developed and evaluated through pilot studies, and further trialled in randomised 325 
controlled trials. The role of a parent / caregiver as support or facilitator within psychological 326 
interventions should also be considered. This approach has been successfully demonstrated in 327 
interventions with adults with intellectual disability (for example, Jahoda et al. 40, 41).  328 
Particularly important in any adaptation or development of interventions is collaboration with 329 
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the key stakeholders: young people with intellectual disability and/or autism, their parents 330 
and families, and the therapists delivering the interventions.  331 
Exclusion of intellectual disability 332 
Inclusion of children and young people with intellectual disability was extremely limited. 333 
Only four studies included participants with an intellectual disability21, 25, 26, 29 and six studies 334 
included participants with a diagnosis of Asperger Syndrome or autism without co-occurring 335 
intellectual disability22-24, 27, 28, 30. No studies involved participants with both intellectual 336 
disability and autism, consistent with a recent meta-analysis demonstrating selection bias 337 
against participants with intellectual disability in autism research42. The exclusion of young 338 
people with intellectual disability was particularly evident in the controlled trials, with only 339 
the physical exercise intervention, involving no cognitive component, including participants 340 
with intellectual disability29. This is a significant gap in the literature in that we have limited 341 
evidence of effective interventions for depression in children with intellectual disability, 342 
despite knowledge that rates of mental health problems, in particular, depression, are 343 
prevalent in this population.  344 
Outcome measures 345 
Outcome measures of depression and depression symptomatology were inconsistent, and in 346 
some cases, not valid measures of depression. While a number of studies used validated 347 
measures and screening tools for depression, including the Revised Children’s Anxiety and 348 
Depression Scale (RCADS) depression subscale23, the Hamilton Depression Rating Scale24, 349 
the DASS Depression scale28, 30, the CDI-II29, and the BDI-II30, others relied on subjective 350 
measurement such as clinical judgement, or changes in behaviour not necessarily indicative 351 
of depression. None of the depression measures used were developed or adapted for people 352 
with intellectual disability and/or autism. Further, selection of outcome measures was not 353 
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suitable in all studies. For example, the DASS is a tool designed for use with a typically 354 
developing adult population yet was used with children and young people as young as 13 355 
years in these studies. Use of suitable depression outcome measures is critical for future 356 
studies to ensure effectiveness in treating depression presenting in children and young people 357 
with intellectual disability and/or autism. Some caregiver-report measures of depressive 358 
symptoms in children and young people with intellectual disability already exist, such as the 359 
Developmental Behavior Checklist 243 and the Anxiety, Depression and Mood Scale44, and 360 
could be used to assess change in depressive symptoms. Some research has used adapted 361 
versions of the Children’s Depression Inventory14 for young people with intellectual 362 
disability45, 46. In addition, adapting existing self-report measures of depression validated for 363 
use with adults with intellectual disability, such as the Glasgow Depression Scale16, for use 364 
with children and young people, could be considered in future research.  365 
Strengths and limitations 366 
The current review was conducted with strong methodological rigour, in line with PRISMA 367 
guidelines and following a pre-registered protocol. Strengths of this review include the broad 368 
definition of psychological and psychosocial therapies used, ensuring all relevant treatments 369 
and interventions were identified, the inclusion of all publication types, including theses, and 370 
no restrictions on date of publication. Non-English publications were excluded, however two 371 
studies were identified from countries without English as a first language. A meta-analysis 372 
was not undertaken due to the small number of studies identified, their poor quality and 373 
moderate-high risk of bias.   374 
Summary and future directions  375 
This systematic review highlights a number of significant gaps in the literature for treatment 376 
of depression for children and young people with intellectual disability and/or autism, in 377 
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particular. The lack of well-designed randomised controlled trials was clear, as was the 378 
exclusion of young people with intellectual disability. The complete lack of research on 379 
psychological interventions for young people with intellectual disability was striking and 380 
concerning. Adaptation and development of specifically tailored psychological and 381 
psychosocial interventions for depression in children and young people with intellectual 382 
disability and/or autism, as well as measures of depression and depressive symptomatology, 383 
is an essential next step in the research.  Future research should also ensure accurate records 384 
of medication are taken and considered when interpreting the effectiveness of a psychological 385 
intervention. 386 
Further, evaluating experiences of both receiving treatment for depression (children and 387 
parents) and delivering treatment (therapists and professionals) is paramount in ensuring that 388 
interventions, both existing, adapted, and newly developed, meet the needs of the end user. 389 
Future research should ensure that families and professionals are consulted on the design of 390 
interventions and evaluations of their experiences are embedded within any study design.  391 
It is important to note that these findings are not unique to the treatment of depression for 392 
children and young people with intellectual disability and/or autism. There is an absence of 393 
intervention research of any psychological treatments for any mental health disorder in this 394 
population7. Further, children and young people with severe intellectual disability are a 395 
particularly vulnerable group, and often neglected in research of mental health problems and 396 
intervention47. As highlighted in a recent systematic review, future research into 397 
psychological treatments for depression for children and young people with intellectual 398 
disability and/or autism should also be supported by the development of appropriate outcome 399 
measures of any mental health symptoms for this population48.   400 
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Table 1 Search terms 574 
Domain Search terms 
Age group adolescen* OR teen* OR youth OR child* OR “young 
person” OR juvenile OR paediatric OR pediatric 
Intellectual disability and/or 
autism spectrum disorder 
(mental* AND (handicap* OR retard* OR disab* OR 
impair* OR defici*)) OR ((learning OR intellect* OR 
development*) AND (difficult* OR disab* OR impair* 
OR disorder* OR handicap*)) OR ((Down* OR “Smith-
Magenis” OR Rett* OR “Lesch-Nyhan” OR “Prader 
Willi” OR Angelman OR “Fragile X” OR “Cri-du-chat” 
OR “Cornelia de Lange” OR “de Lange” OR “Rubenstein-
Taybi” OR velocardiofacial) AND syndrome*) OR 
(moron OR imbecile OR feeble-minded) OR (autis* OR 
ASD OR Asperger*) 
Depression (depress* AND (symptom* OR disorder OR thought* OR 
behavi*)) OR ((affective OR mood* OR emotion*) AND 
(disorder OR symptom* OR disturb*)) OR (depression 
OR dysthymi* OR melancholy*) 
Treatment or intervention therap* OR treat* OR intervention OR management OR 
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hours per week) - 
occurred both at 














chlorpromazine at 7 
months 



















improved coping skills, 
improvement in ability to 
express feelings, and 
improve capacity for self-
advocacy 
 
Behavioural treatment - 
decrease in frequency of 
maladaptive (target) 
behaviours, recurrence of 
oppositional behaviours 
in last 2 months of 
treatment 
 
Improvement in GAF 
(DSM-IV49) score from 
25 (beginning of 
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Homunculi) – a 
meta-cognitive 
visual aid using 
development of 
characters to 
support the use of 





authors for people 
with autism 






anger and stress 
















Emotional state on all 
scales, including 
depression, reduced to 
lower than clinically 
significant levels and 
were at the mean for the 




competence and social 
skills, although still at 
lower levels than same-
aged peers. 
 
Reduction in concerns 
expressed by teacher 
about school adaptation.  
High 




N = 1 
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CBT for low self-
esteem with 
adaptations made 
for autism, although 
what adaptations 
were made was not 
20 sessions Progress 
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Session 6, 




reduction in anxiety and 
depression at the end of 
treatment. Depression 
subscale score just below 









































































Medication – both 
participants had 
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Both participants saw a 
reduction in scores on the 
Hamilton Depression 
Rating Scale to below 
clinically significant 
levels. Participants 
remained free from 
depressive symptoms 
over the follow-up period. 
 
Improvement in scores on 
Social Functioning 
Questionnaire at the end 





















Note: DSM = Diagnostic and Statistical Manual of Mental Disorders; GAF = Global Assessment of Functioning; WISC = Wechsler Intelligence Scale for 
Children; FSIQ = Full Scale Intelligence Quotient; CBT = cognitive behavioural therapy; ICD-10-DCR = The International Classification of Diseases-10 
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N = 42 
72% male 
Mage = 20.6 
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N = 49 
59% male 
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Sample Size & Description Randomisation Assessment 
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The VC and 
NC groups 
did not differ. 










(SD = 1.37 
years), 






VIQ > 85 
N = 11 
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from pre- to 
post-
intervention 



















Note: BASC-2 = Behaviour Assessment System for Children, 2nd edition; DASS = Depression, Anxiety and Stress Scales; ATQ = Automatic Thoughts 
Questionnaire; ASSQ = Anxious Self-Statements Questionnaire; VABS = Vineland Adaptive Behavior Scales; CDI = Children’s Depression Inventory; BDI 


































13936 records found 
PsycINFO, 3350 records 
Medline, 2178 records 
Embase, 2976 records 
CINAHLPlus, 1079 records 
Web of Science, 2936 records 
Scopus, 1417 records 
9343 records for full title and 
abstract screen 
114 records for full text review 
4593 duplicates removed 
9229 studies excluded 
104 studies excluded 
n = 55 no diagnosis of depression 
n = 25 wrong population (adult, no 
intellectual disability or autism)  
n = 6 change in depressive 
symptoms not reported 
n = 13 no treatment or treatment not 
targeting depression 
n = 4 not a psychological 
intervention 
n = 1 preventative intervention 
10 studies included in review 
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